Arcadia Biosciences Inc Q2 2020 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Benjamin David Klieve - National Securities Corporation, Research Division - Analyst : So a few here from me. First of all, kind of building off some of the conversation you just had on the wheat side. On these distribution agreements, I mean, 3 separate agreements. I'm sure the structure is different for all 3. Can you just kind of comment on -- and I know that it's not -- I know that these aren't officially signed yet, you're still working on the terms. But I mean are each of these distribution agreements that you believe are going REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. AUGUST 13, 2020 / 8:30PM, RKDA.OQ - Q2 2020 Arcadia Biosciences Inc Earnings Call to have initial revenues, say, within the next 12 months? Or are there kind of long evaluation processes with these that you're expecting, so these may be kind of longer term, maybe more longer-term in nature?

Question: Benjamin David Klieve - National Securities Corporation, Research Division - Analyst : Got it. And then the -- so the GoodMills and the Corner Foods agreements, are those both selling the commodity flour products, or are either of those going to be selling CPG products in whatever form -- and whatever form you may have.

Question: Benjamin David Klieve - National Securities Corporation, Research Division - Analyst : Got it. Got it, got it. Okay. Turning over to hemp, I mean there's a lot of unpack that you both explained in your prepared remarks. I guess, I know there's an incredible amount of uncertainty, it sounds like. But what -- from a regulatory perspective, I mean, there -- is there an event? Is there -- that bill you referred to coming from the FDA last month? Is there something from a regulatory front that you think is coming down the pike here in the relatively near term, that's going to turn -- that's going to turn this market on relatively quickly? And if so, what are the specific things that we can look for from that perspective?

Question: Benjamin David Klieve - National Securities Corporation, Research Division - Analyst : Okay. And then last question for me, and I'll get back in queue, still on the hemp front. To what degree are -- the hemp growers that were in your backlog, to what degree are they planting varieties for industrial use or for grain use rather than the CBD variety that you may be providing. Is that REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. AUGUST 13, 2020 / 8:30PM, RKDA.OQ - Q2 2020 Arcadia Biosciences Inc Earnings Call a dynamic to consider? Or are they just -- are they simply waiting for approval so they can plant the CBD varieties? Are they planting some other crops? I mean what are these farmers doing rather than planting your varieties?